
Response To Alexandros Contra Me On Ivermectin
Astral Codex Ten Podcast
00:00
Blinertumumab Trial - A Comparison of Vaccines and Controls
The requirement of rigorous eligibility criteria in the Blinertumumab clinical study, such as Eastern Cooperative Ontology Group status of two or lower and absence of abnormal lab values during screening, may increase the chances of better outcomes. Scott writes, Compare this to how the Barodis study discusses its synthetic control group. The control data was from contemporary infected subjects in Australia obtained from published COVID tracking data. In Barodiet L synthetic control group 70 of 600 that's 11.5% of patients required hospitalization. But the US hospitalization rate appears to be about 1% for unvaccinated individuals. This seems very relevant to this study finding that Ivermectin decreases hospital
Transcript
Play full episode